Glooko is a Healthtech company based in Palo Alto, California. It has raised $171M in total funding. Latest round: Series F.
Glooko funding overview
Glooko is a Healthtech company based in Palo Alto, California. Glooko has raised $171M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series F announced in October 2024. The round record for Glooko runs through 2024; nothing later has been disclosed. Investors on record include Georgian, Health Catalyst Capital, Canaan Partners, Novo Nordisk, Insulet, Mayo Clinic and 3 others. 9 distinct backers are named across the disclosed rounds.
Glooko at a glance
Total raised
$171M
Latest round
Series F
Latest round date
October 2024
Industry
Healthtech
Headquarters
Palo Alto, California
Notable investors
Georgian, Health Catalyst Capital, Canaan Partners, Novo Nordisk, Insulet, Mayo Clinic, Medtronic, Samsung
Frequently asked about Glooko funding
How much has Glooko raised?
Glooko has raised $171M in total disclosed funding across the rounds on record.
Who has invested in Glooko?
Georgian, Health Catalyst Capital, Canaan Partners, Novo Nordisk, Insulet, Mayo Clinic are named among the investors backing Glooko.
What was the latest Glooko funding round?
The most recent disclosed round is a Series F, announced in October 2024.
Where is Glooko based?
Glooko is based in Palo Alto, California.
What sector does Glooko operate in?
Glooko is tracked under Healthtech from Palo Alto, California, with $171M in disclosed funding.
When did Glooko last raise?
The last disclosed Glooko round closed in October 2024 at Series F.
We update the Glooko record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Healthtech companies in Palo Alto and their backers are listed below.
